<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02726048</url>
  </required_header>
  <id_info>
    <org_study_id>CIA178</org_study_id>
    <nct_id>NCT02726048</nct_id>
  </id_info>
  <brief_title>Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany</brief_title>
  <official_title>Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigation is designed to evaluate the performance, comfort and ease of use of the
      Simplus and Eson masks amongst NIV patients who are currently on Bi-level therapy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to 40 NIV patients who currently use a full face mask or a nasal mask will be recruited.
      They will be issued a Simplus (if they are existing full face users) or Eson (if they are
      existing nasal users) to use in-home for 2 weeks. This will consists of male and female
      participants who have been prescribed with NIV therapy for at least 3 months.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Objective Leak data</measure>
    <time_frame>2 weeks</time_frame>
    <description>Obtained from the participant's device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective measurement of Leak</measure>
    <time_frame>2 weeks</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective measurement of Comfort</measure>
    <time_frame>2 weeks</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective measurement of Ease of Use</measure>
    <time_frame>2 weeks</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Obesity Hypoventilation Syndrome</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Neuromuscular Disease</condition>
  <arm_group>
    <arm_group_label>Full face/Nasal masks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Simplus/Eson</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Simplus/Eson</intervention_name>
    <description>Released product Simplus and Eson masks</description>
    <arm_group_label>Full face/Nasal masks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18+

          -  Existing full face mask user or a nasal mask user

          -  Prescribed NIV therapy for at least 3 months

        Exclusion Criteria:

          -  Inability to give informed consent

          -  Pregnant or think they may be pregnant

          -  Anatomical or physiological conditions making NIVtherapy inappropriate

          -  Patients who are in a coma or decreased level of consciousness

          -  Existing Simplus and Eson users
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingo Fietze, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2016</study_first_submitted>
  <study_first_submitted_qc>March 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2016</study_first_posted>
  <last_update_submitted>November 1, 2016</last_update_submitted>
  <last_update_submitted_qc>November 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Neuromuscular Diseases</mesh_term>
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

